心脉医疗: 心脉医疗：公司章程（2025年8月修订）

General Provisions - The company aims to protect the legal rights of shareholders, employees, and creditors while regulating its organization and behavior according to relevant laws [1][2] - Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. was established as a joint-stock company in accordance with the Company Law and other regulations [1][2] - The company was approved by the China Securities Regulatory Commission and listed on the Shanghai Stock Exchange on July 22, 2019, with an initial public offering of 18 million shares [1][3] Company Structure - The registered capital of the company is RMB 123.262117 million [2] - The company is a permanent joint-stock company, and the chairman or general manager serves as the legal representative [2][3] - Shareholders are liable for the company's debts only to the extent of their subscribed shares, while the company is liable for its debts with all its assets [2][3] Business Objectives and Scope - The company's business objective is to enhance management efficiency and maximize economic benefits to provide satisfactory returns to shareholders [4] - The business scope includes the sale of medical devices, technical services, import and export of goods, and property management, among others [4][5] Shares - The company's shares are issued in the form of stocks, with each share having a par value of RMB 1 [5][6] - The total number of shares issued by the company is 123.262117 million, all of which are ordinary shares [5][6] - The company cannot acquire its own shares except under specific circumstances, such as capital reduction or mergers [6][7] Shareholder Rights and Responsibilities - Shareholders have rights to dividends, voting, and supervision of company operations, and they can request to convene shareholder meetings [10][11] - Shareholders must comply with laws and the company's articles of association, and they are liable for damages caused by abusing their rights [15][16] - Major shareholders (holding over 5% of shares) must report any pledges of their shares to the company [15][16] Shareholder Meetings - The company holds annual shareholder meetings within six months after the end of the fiscal year, and special meetings can be called under certain conditions [22][24] - Shareholder proposals must be submitted in writing and can be made by shareholders holding at least 1% of the shares [26][27] - The company must provide legal opinions on the validity of the meeting procedures and the qualifications of attendees [53][54]